Santen Pharmaceutical Co., Ltd. (SNPHY)
10.69
-0.13
(-1.20%)
USD |
OTCM |
May 08, 16:00
Santen Pharmaceutical EPS Diluted (Quarterly) : 0.158 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Takeda Pharmaceutical Co., Ltd. | 0.2099 |
| Daiichi Sankyo Co., Ltd. | 0.3035 |
| Eisai Co., Ltd. | 0.0988 |
| Chugai Pharmaceutical Co., Ltd. | 0.2235 |
| Ono Pharmaceutical Co., Ltd. | 0.1329 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 52.86M |
| Revenue (Quarterly) | 473.06M |
| Total Expenses (Quarterly) | 421.94M |
| Enterprise Value | 3.271B |
| Gross Profit Margin (Quarterly) | 52.88% |
| Profit Margin (Quarterly) | 11.17% |
| Earnings Yield | 5.72% |
| Operating Earnings Yield | 7.70% |
| Normalized Earnings Yield | 5.723 |